Data collection and quality assessment In accordance with the established inclusion criteria, two reviewers meticulously extracted the following data from the selected studies: the name of the first author, year of publication, participants race and ethnicity, study design, number of cases and controls, family history of cancer, body mass index, age, clinical outcomes, type of drug administered, and stages of CRC
Small Businesses for Proof-of-Concept Research - July 6, 2023 DHS Opens 23.1 Small Business Innovation Research Solicitation - December 19, 2022 DHS Announces New 23.1 Small Business Innovation Research Pre-Solicitation - November 18, 2022 DHS Awards $9.8M for Small Businesses to Develop Security Technology Prototypes - June 30, 2022 DHS SBIR to Host First Responder Technology Showcase - March 22, 2022 DHS SBIR Seeks Solutions to Detect Survivors in a Building Collapse - February 7, 2022 DHS S&T Announces Small Business Innovation Research Pre-Solicitation - November 22, 2021 The DHS SBIR Program issues an annual solicitation with topics that cover DHS mission areas for which proposals are sought
Headache, particularly at initiation Mild anxiety or restlessness with some compounds Nasal irritation (intranasal administration) Sleep disturbance if dosed too close to bedtime Rare: Mood changes or emotional lability Dihexa (PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a potent hepatocyte growth factor (HGF) receptor agonist originally developed at Washington State University
APLB Exosome Niacinamide Serum The APLB Exosome Niacinamide Serum is an advanced Korean serum designed to hydrate, brighten, and support smoother, healthier-looking skin using regenerative-inspired skincare technology
